Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua P Frederick

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
The Journal of Biological Chemistry|February 3, 2004
Transforming growth factor-beta1 inhibition of vascular smooth muscle cell activation is mediated via Smad3Mark W Feinberg, Masafumi Watanabe, Maria A Lebedeva, et al.
Circulation Research|January 31, 2004
Essential role for Smad3 in regulating MCP-1 expression and vascular inflammationMark W Feinberg, Koichi Shimizu, Maria Lebedeva, et al.
Science Translational Medicine|February 1, 2019
Durable anticancer immunity from intratumoral administration of IL-23, IL-36γ, and OX40L mRNAsSusannah L Hewitt, Ailin Bai, Dyane Bailey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
Intratumoral IL12 mRNA Therapy Promotes TH1 Transformation of the Tumor MicroenvironmentSusannah L Hewitt, Dyane Bailey, John Zielinski, et al.
Cancer Discovery|August 8, 2024
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 StudyJustin F Gainor, Manish R Patel, Jeffrey S Weber, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
The Journal of Biological Chemistry|February 3, 2004
Transforming growth factor-beta1 inhibition of vascular smooth muscle cell activation is mediated via Smad3Mark W Feinberg, Masafumi Watanabe, Maria A Lebedeva, et al.
Circulation Research|January 31, 2004
Essential role for Smad3 in regulating MCP-1 expression and vascular inflammationMark W Feinberg, Koichi Shimizu, Maria Lebedeva, et al.
Science Translational Medicine|February 1, 2019
Durable anticancer immunity from intratumoral administration of IL-23, IL-36γ, and OX40L mRNAsSusannah L Hewitt, Ailin Bai, Dyane Bailey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
Intratumoral IL12 mRNA Therapy Promotes TH1 Transformation of the Tumor MicroenvironmentSusannah L Hewitt, Dyane Bailey, John Zielinski, et al.
Cancer Discovery|August 8, 2024
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 StudyJustin F Gainor, Manish R Patel, Jeffrey S Weber, et al.
Pageof 2